Brief: Takeda Pharmaceutical Company Reports 5.2% Passive Stake In Equillium Inc - SEC Filing
19/01/2024 11:22
Jan 19 (Reuters) - Takeda Pharmaceutical Co Ltd
4502.T :
* TAKEDA PHARMACEUTICAL COMPANY LIMITED REPORTS 5.2% PASSIVE
STAKE
IN EQUILLIUM INC AS OF DECEMBER 31, 2023 - SEC FILING
Further company coverage: 4502.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Equillium
See all newsBrief: Equillium Receives Australian Regulatory Clearance To Initiate First-In-Human Clinical Trial Of Eq504
Equillium Inc reports results for the quarter ended June 30 - Earnings Summary
Equillium Q2 post narrower net loss than expected; starts R&D initiatives
Equillium Inc expected to post a loss of 5 cents a share - Earnings Preview
Equillium Q1 net loss, profit miss analyst expectations